These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24673549)

  • 41. Isolated myelitis in a patient with Behcet's disease during golimumab therapy.
    Kon T; Hasui K; Suzuki C; Nishijima H; Tomiyama M
    J Neuroimmunol; 2021 May; 354():577533. PubMed ID: 33684832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pediatric familial neuromyelitis optica in two sisters with long term follow-up.
    Chuquilin M; Mullaguri N; Weinshenker B
    J Clin Neurosci; 2016 Jul; 29():183-4. PubMed ID: 26898580
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Behçet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis.
    Adler S; Baumgartner I; Villiger PM
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):607-11. PubMed ID: 22162223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease.
    Triolo G; Vadalà M; Accardo-Palumbo A; Ferrante A; Ciccia F; Giardina E; Citarrella P; Lodato G; Licata G
    Ann Rheum Dis; 2002 Jun; 61(6):560-1. PubMed ID: 12006336
    [No Abstract]   [Full Text] [Related]  

  • 45. Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis.
    Takase K; Ohno S; Ideguchi H; Uchio E; Takeno M; Ishigatsubo Y
    Rheumatol Int; 2011 Feb; 31(2):243-5. PubMed ID: 19816689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tubercular longitudinally extensive transverse myelitis with lower motor neuron paralysis.
    Goyal MK; Lal M
    Trop Doct; 2021 Jan; 51(1):117-119. PubMed ID: 32933380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infliximab in the treatment of Budd-Chiari syndrome in Behçet's disease.
    Santos LB; Rigueira J; Vilas AP
    Reumatismo; 2019 Oct; 71(3):163-165. PubMed ID: 31649380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. "Fulminant" Behçet disease.
    Zaidan M; Lidove O; Sacré K; Klein I; Papo T
    Presse Med; 2011 Nov; 40(11):1087-9. PubMed ID: 21658901
    [No Abstract]   [Full Text] [Related]  

  • 49. Good response to infliximab in a patient with deep vein thrombosis associated with Behçet disease.
    Yoshida S; Takeuchi T; Yoshikawa A; Ozaki T; Fujiki Y; Hata K; Makino S; Hanafusa T
    Mod Rheumatol; 2012 Sep; 22(5):791-5. PubMed ID: 22245952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute cervical segmental denervation in neuromyelitis optica spectrum disorder.
    Mingbunjerdsuk P; Katirji B
    J Clin Neuromuscul Dis; 2014 Dec; 16(2):90-7. PubMed ID: 25415521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case of longitudinally extensive transverse myelitis with an isolated pontine lesion following epidural and spinal anesthesia for cesarean section.
    Kitazaki Y; Ueno A; Maeda K; Asano R; Satomi H; Nishio T; Nakamoto Y; Hamano T
    eNeurologicalSci; 2020 Dec; 21():100264. PubMed ID: 32885056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Infliximab in refractory uveitis due to Behçet's disease.
    Wechsler B; Sablé-Fourtassou R; Bodaghi B; Huong DL; Cassoux N; Badelon I; Fain O; LeHoang P; Piette JC
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years.
    Kanemaru H; Makino T; Jinnin M; Yonemitsu A; Makino K; Ihn H
    J Dermatol; 2013 Aug; 40(8):632-4. PubMed ID: 23724912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.
    Pipitone N; Olivieri I; Padula A; D'angelo S; Nigro A; Zuccoli G; Boiardi L; Salvarani C
    Arthritis Rheum; 2008 Feb; 59(2):285-90. PubMed ID: 18240181
    [No Abstract]   [Full Text] [Related]  

  • 55. Etiological spectrum, clinico-radiological profile and treatment outcomes of longitudinally extensive transverse myelitis - A prospective study from Northwest India.
    Choudhary A; Bhargava A; Khichar S; Pradhan S
    J Neuroimmunol; 2021 Feb; 351():577456. PubMed ID: 33341581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical characteristics, prognosis, and seropositivity to the anti-aquaporin-4 antibody in Korean patients with longitudinally extensive transverse myelitis.
    Kim SH; Kim SM; Vincent A; Ahn SW; Hong YH; Park KS; Sung JJ; Lee KW
    J Neurol; 2010 Jun; 257(6):920-5. PubMed ID: 20049472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders.
    Hu H; You X; Ye J
    Mult Scler Relat Disord; 2018 Apr; 21():78-83. PubMed ID: 29499441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential diagnosis and prognosis for longitudinally extensive myelitis in Buenos Aires, Argentina.
    Carnero Contentti E; Hryb JP; Leguizamón F; Di Pace JL; Celso J; Knorre E; Perassolo MB
    Neurologia; 2017 Mar; 32(2):99-105. PubMed ID: 26526674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful use of infliximab in a patient with neuro-Behçet's disease.
    Abalos-Medina GM; Sánchez-Cano D; Ruiz-Villaverde G; Ruiz-Villaverde R; Quirosa Flores S; Raya Alvarez E
    Int J Rheum Dis; 2009 Sep; 12(3):264-6. PubMed ID: 20374357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients.
    Saison J; Costedoat-Chalumeau N; Maucort-Boulch D; Iwaz J; Marignier R; Cacoub P; Vital-Durand D; Hot A; Tebib J; Aumaitre O; Schleinitz N; Sarrot-Reynauld F; Broussolle C; Sève P
    Lupus; 2015 Jan; 24(1):74-81. PubMed ID: 25117654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.